-
Taiwan lawmakers approve $7.6 bn drone budget as China threat grows
-
Norway's King Harald, 89, in 'extremely serious' condition
-
TechCentral.ie Daily Briefing: Agentic AI Firm Doubles Headcount to 60
-
How a glacier collapse may have caused Nepal-Tibet disaster
-
KiiChain Integrates TRON to Expand 24/7 On-Chain FX and Stablecoin Payments
-
Harmovest Capital Strengthens Global Financial Services Through Technology and Compliance
-
Japan to survey animal cafes over hygiene, welfare concerns
-
Nvidia to buy AI platform Hugging Face for $12.9 bn: report
-
Desperate families search for missing after Nepal floods
-
Palace intrigue in Uganda as succession battle heats up
-
The missing in Nepal-Tibet flash floods
-
'Housing First' approach gets Swedish city's homeless off streets
-
Search for 1,300 missing after deadly Nepal-Tibet floods
-
Czech duo Muchova and Mensik win US Open mixed doubles title
-
Once a top export, prized Kashmir carpet fades
-
Japan's 'polka dot queen' artist Yayoi Kusama dies aged 97
-
Search for 1,000 missing after deadly Nepal-Tibet floods
-
Nepal-Tibet disaster: what we know
-
Park So-yeon first woman to play for eSports powerhouse South Korea
-
China deploys record number of ships around Taiwan as pressure grows
-
Yayoi Kusama: Japan's kaleidoscopic, troubled 'polka dot queen'
-
Ruthless Bayern target treble as rivals reboot on Bundesliga return
-
Euro champ Hunt 'on her toes' against world's best in Zurich 100m
-
What experts know so far about Nepal's deadly floods
-
Asian chip firms lifted by Nvidia forecast but broader markets struggle
-
UEFA set to withdraw FIFA boycott threat ahead of Champions League draw
-
Search for missing after Nepal-Tibet floods kill 165
-
Sumo moves to beat Japan summer heat as temperatures rise
-
Qantas says profits slump as fuel costs surge
-
'Be more honest': Markets crave clarity from cryptic Fed chair
-
Lofty bond yields, Bessent's intervention pose challenge to Fed's Warsh
-
Climate change leaves its mark on America's largest reservoir
-
The foreigners missing in Nepal's flash floods
-
CIA director warned Russia not to attack NATO members: US media
-
Bond yields are surging: Here's why that could spell trouble
-
Search for missing after Nepal-Tibet floods kills at least 160
-
Fed's Cook rejects Trump mortgage fraud claims
-
Empire Metals Limited Announces Interim Results
-
Guardian Metal Resources PLC Announces Pilot Mountain Technical Report Summary
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 27
-
Meta, US states agree $18 bn settlement in landmark teen safety case
-
Police probe 'assault allegations' after Carse's nightclub incident
-
What scientists know so far about Nepal's deadly floods
-
How we might hear new Dolly Parton music in the future
-
US general visits Colombia to discuss war on drugs
-
Nvidia doubles revenue, forecasts even more AI spending
-
Meta settlement puts social media industry on notice: 'There will be more'
-
Canada renews push to boycott US products
-
NFL owners approve record Seahawks sale
-
Savio scores on debut as Spurs set-up League Cup tie with Liverpool
Moderna to Present at Upcoming Conferences in March 2026
CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / February 19, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
TD Cowen 46th Annual Healthcare Conference, on Tuesday, March 3rd at 1:50pm ET
Barclays 28th Annual Global Healthcare Conference, on Tuesday, March 10th at 9:30am ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
H.Thompson--AT